Basilea Pharmaceutica AG (SWX:BSLN)

Switzerland · Delayed Price · Currency is CHF

66.70

+2.20 (3.41%)

Sep 11, 2026, 5:30 PM CET

Basilea Pharmaceutica AG Financials Overview

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	247.42	232.38	208.54	157.63	147.77	148.12
Revenue Growth	6.47%	11.43%	32.30%	6.68%	-0.24%	16.06%
Gross Profit	95.27	87.16	92.72	52.99	49.36	30.89
Operating Income	59.88	52.25	61.7	21.91	20.81	3.01
Net Income	52.38	40.24	77.59	10.45	12.15	-6.83
Earnings Per Share	4.01	3.14	5.82	0.86	1.02	-0.58
EPS Growth	27.62%	-46.05%	577.28%	-15.69%	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Japan	86.6	69.6	59.6	64	56.5
Ireland	78.1	93.7	68.7	41.3	62.1
USA	37	12.3	6.1	9.8	14.5
Uruguay	8.7	12.1	10.2	7.4	3.4
China	6.7	2.3	2.3	0.1	-
Other	15.3	18.5	-	0.6	0.7
Total	232.4	208.5	157.6	147.8	148.1

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	173.05	159.8	120.71	59.93	84.66	148.7
Total Debt	83.44	89.22	111.67	128.61	187.14	218.96
Net Cash (Debt)	89.61	70.58	9.04	-68.67	-102.48	-70.26
Net Cash Growth	26.96%	680.74%	-	-	-	-
Net Cash Per Share	6.56	5.16	0.65	-5.66	-8.58	-6.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	58.01	62.09	74.36	14.25	7.06	-32.02
Capital Expenditures	-2.71	-2.62	-1.71	-0.81	-3.14	-0.58
Free Cash Flow	55.3	59.47	72.65	13.43	3.92	-32.6
Free Cash Flow Growth	-7.01%	-18.14%	440.89%	242.83%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.51%	37.51%	44.46%	33.62%	33.40%	20.86%
Operating Margin	24.20%	22.48%	29.59%	13.90%	14.09%	2.03%
Pretax Margin	23.72%	19.74%	28.90%	6.64%	8.19%	-4.59%
Profit Margin	21.17%	17.32%	37.21%	6.63%	8.22%	-4.61%
FCF Margin	22.35%	25.59%	34.84%	8.52%	2.65%	-22.01%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.63	16.70	6.46	40.47	44.94	-
Forward PE	15.27	13.26	10.63	15.17	98.35	225.87
P/FCF Ratio	14.98	11.30	6.90	31.48	139.32	-
PS Ratio	3.35	2.89	2.40	2.68	3.69	3.27